CAS 1023744-69-5

Formula: C28H36O7

InChI: InChI=1S/C28H36O7/c1-10-15(2)28(29)35-27-23-19(14-21(31-6)25(27)33-8)12-17(4)16(3)11-18-13-20(30-5)24(32-7)26(34-9)22(18)23/h10,13-14,16-17H,11-12H2,1-9H3/b15-10-/t16-,17+/m1/s1

InChI key: DSAHZJYWMDAZSA-KNUIFBHBSA-N

SMILES: C/C=C(/C)\C(=O)OC1=C2C(=CC(=C1OC)OC)C[C@@H]([C@@H](CC3=CC(=C(C(=C32)OC)OC)OC)C)C

Negsehisandrin G

CAS: 1023744-69-5

Negsehisandrin G

Formula: C₂₈H₃₆O₇

Purity: ≥95%

Molecular weight: 484.58

Ref: 54-OR1133459

Negsehisandrin G

CAS: 1023744-69-5

Formula: C₂₈H₃₆O₇

Purity: 95%

Molecular weight: 484.5812

Ref: IN-DA00900O

Angeloyl-(+)-gomisin K3

CAS: 1023744-69-5

Negsehisandrin G is a natural product

Formula: C₂₈H₃₆O₇

Purity: 98%

Color and Shape: Solid

Molecular weight: 484.589

Ref: TM-TN1974

Negsehisandrin G

CAS: 1023744-69-5

Formula: C₂₈H₃₆O₇

Purity: 95%~99%

Molecular weight: 484.589

Ref: BP-BP3265

Negsehisandrin G

Controlled Product

CAS: 1023744-69-5

Negsehisandrin G is an activator of transcriptional promoters and a prodrug that is metabolized to schisandrol, schisanhenol, and isokadsuranin. Negsehisandrin G has been shown to inhibit the activity of farnesoid X receptor (FXR), which is a nuclear receptor involved in the regulation of bile acid synthesis. In addition, it has been found to have anti-inflammatory properties. This product has ethnopharmacological uses to treat various diseases, including rheumatoid arthritis and cardiovascular disease. Negsehisandrin G may be used as a medicine for the treatment of hypertension or hyperlipidemia.

Purity: Min. 95%

Ref: 3D-FN74474